Notable insider buying and selling activity across public companies.
Tracking and analysis of reported insider transactions, including executive and director buying or selling. Insider activity can offer insight into internal confidence, valuation perceptions, and potential inflection points.
13,303 total articles
FuelCell Energy Inc. (NASDAQ:FCEL) Executive Vice President and Chief Product & Technology Officer Achanta Shankar executed a stock sale under a pre-established trading plan. The transaction occurred alongside an expanded underwritten public offering and approval of a significant financing package from the Export-Import Bank of the United States fo…
Affiliates of private equity firm Silver Lake, along with Dell Technologies director Egon Durban, executed the sale of 636 Dell Class C Common Stock shares on July 6, 2026, totaling approximately $261,081. The transactions, priced between $405.36 and $418.49 per share, followed the conversion of an equivalent number of Class B shares. This activity…
Sprouts Farmers Market CEO Jack Sinclair executed a series of stock sales totaling approximately $1.86 million over two days in July 2026, adhering to a Rule 10b5-1 trading plan. The transactions occurred as the company's shares traded near $80, reflecting a significant annual decline. Despite the executive sale, Sprouts maintains a robust 37% retu…
Patricia Gallup, Chairman and Chief Administrative Officer of PC Connection Inc. (NASDAQ: CNXN), conducted a series of share sales totaling $1,049,626 through the David Hall Trust 2003 between July 6 and July 7, 2026. The transactions, executed under a pre-established Rule 10b5-1 plan, occurred as the stock approached its 52-week high of $75.30. De…
Matthew Crowley, Executive Vice President of Global Business Units at Jabil Inc. (NASDAQ:JBL), executed a sale of 94 shares of the company's common stock on July 6, 2026. The transaction, valued at $32,430, occurred at a per-share price of $345.00. This sale follows a period of market fluctuation where Jabil's stock declined by 13% over the precedi…
Jason P. Rhodes, a director at Dyne Therapeutics, Inc. (NASDAQ:DYN), executed a significant sale of company stock totaling approximately $17.86 million. The transactions, which occurred on July 6 and July 7, 2026, involved the liquidation of 777,451 shares through a pre-established Rule 10b5-1 trading plan. This activity takes place as Dyne Therape…
Core & Main, Inc. (NYSE: CNM) has disclosed a recent equity transaction involving its director, James D. Hope. The filing indicates a direct purchase of Class A Common Stock, bringing his total direct holdings to 11,805 shares. This transaction occurs against a backdrop of significant corporate financial restructuring, including the pricing of new …
Mueller Water Products director Brian C. Healy has increased his direct ownership stake in the company through a recent stock purchase. The acquisition, executed under a pre-established trading plan, brings his total holdings to 24,946 shares. This insider activity occurs as the stock trades below certain valuation metrics, even as the company repo…
On July 6, 2026, Dell Technologies (NASDAQ:DELL) reported significant insider transactions involving affiliates of Silver Lake and director Egon Durban. The group sold approximately $25.9 million worth of Class C Common Stock, with share prices ranging between $405.36 and $418.49. This selling activity occurred despite Dell's stock closing at $432,…
Silver Lake Technology Investors IV, L.P., a key affiliate of private equity firm Silver Lake, has executed a series of transactions involving Dell Technologies Inc. (NYSE:DELL), resulting in the sale of 1,409 shares of Class C Common Stock. The divestment, valued at approximately $578,426, occurred against a backdrop of significant stock appreciat…
Robert Joseph Deshaies, Chief Operating Officer of Benefits at WEX Inc. (NASDAQ: WEX), has executed a sale of 2,000 shares of the company's common stock on July 6, 2026. The transaction, valued at $296,795, was carried out through a Rule 10b5-1 trading plan adopted earlier in the year. This sale follows a period of significant corporate activity fo…
Egon Durban, a director at Dell Technologies Inc. (NASDAQ:DELL) and Co-CEO of Silver Lake Group, L.L.C., along with affiliated Silver Lake entities, reported the sale of Class C Common Stock valued at approximately $15.18 million on July 6, 2026. The transaction involved the disposition of 33,982 shares, with prices ranging from $405.00 to $419.06 …
Clark Jermoluk Founders Fund I LLC, a significant ten percent shareholder in Ibotta, Inc. (NASDAQ:IBTA), executed a substantial divestment of its holdings in early July 2026. The fund sold 500,000 shares of Ibotta's Class A Common Stock on July 6, 2026, at an average price of $30.15 per share. This transaction resulted in a total realized value of …
Egon Durban, a director at Dell Technologies Inc. (NASDAQ:DELL), alongside affiliated Silver Lake entities, executed sales totaling approximately $29.9 million in Dell Class C Common Stock on July 6, 2026. The transaction involved 72,766 shares priced between $405.36 and $418.49. This sale occurs as Dell's stock has surged 241% over the past year t…
Neil Gregory Almstead, PTC Therapeutics' Chief Technical Operations Officer, executed a series of transactions on July 6 and 7, 2026, selling approximately $4.1 million in common stock while acquiring shares valued at $1.8 million. All activity was conducted under a Rule 10b5-1 trading plan established in November 2025. The trades occurred as the s…
Mark Boulding, Executive Vice President and Chief Legal Officer at PTC Therapeutics, Inc. (NASDAQ: PTCT), executed a series of transactions involving the company's common stock on July 6, 2026. The executive sold 5,079 shares valued at $432,117, while simultaneously acquiring an equivalent number of shares through stock option exercises. These move…
Hershey Trust Co. Trustee in Trust for Milton Hershey School, a significant 10% owner of The Hershey Company (NASDAQ:HSY), executed a series of stock sales totaling 30,000 shares between July 6 and July 8, 2026. The transactions, valued at approximately $5.3 million, were distributed across three consecutive days at varying price points. This insid…
Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM) Chief Financial Officer Eric Bjerkhot executed a series of stock sales on July 6, 2026, totaling $611,273 in value. The transactions, comprising 5,000 shares of common stock, were facilitated through a Rule 10b5-1 trading plan established earlier in the year. This executive divestment takes place against a …
Relay Therapeutics, Inc. (NASDAQ: RLAY) President and CEO Sanjiv Patel executed a sale of 48,199 shares on July 7, 2026, generating $943,736. The transaction, structured under a Rule 10b5-1 plan adopted in October 2025, occurred as the stock approached its 52-week high of $20.20. Prior to the sale, Patel acquired 3,056 shares at $6.95 per share in …
Mirum Pharmaceuticals CEO Christopher Peetz sold 20,000 shares for approximately $2.4 million following the exercise of employee stock options. The transactions, executed under a Rule 10b5-1 plan, occurred as the stock trades near its 52-week high. Peetz retains significant holdings through direct and trust accounts. Recent company developments inc…
Donald A. Bergstrom, President and Chief Scientific Officer at Relay Therapeutics, Inc., completed a sale of 8,660 shares of the company's common stock on July 6, 2026. The transaction, valued at $162,028, was executed under a Rule 10b5-1 trading plan established in late 2025. This divestment occurs against a backdrop of significant price appreciat…
Hartree Partners, LP, a major shareholder in Hudson Technologies Inc. (NASDAQ:HDSN), has increased its position by purchasing an additional $31,351 in common stock. The transactions occurred over two days in early July 2026, bringing Hartree's total holdings to 4,976,536 shares, representing a ten percent ownership stake. This accumulation follows …
Energy Vault Holdings, Inc. (NASDAQ:NRGV) Chief Financial Officer Michael Thomas Beer conducted two significant transactions on July 6, 2026. Beer sold 65,000 shares of common stock valued at $265,200, executed under a Rule 10b5-1 trading plan. The shares were sold at $4.08 per share. On the same day, Beer acquired 50,000 shares through the exercis…
Jon Ayotte, EverQuote's Chief Accounting Officer, executed a series of transactions in early July 2026 under a pre-existing Rule 10b5-1 plan, selling 881 shares while simultaneously exercising options to acquire 3,156 shares. These moves occur against a backdrop of robust Q1 2026 financial performance that beat consensus estimates on both earnings …
David Brainard, Chief Technology Officer at EverQuote, Inc. (NASDAQ:EVER), executed a series of stock sales totaling $126,508 on July 6, 2026. The transactions involved the disposition of 4,960 shares of EverQuote Class A Common Stock, conducted through a Rule 10b5-1 trading plan established in September 2025. This structured approach allows inside…
